Aster Capital Management DIFC Ltd Buys 736 Shares of McKesson Co. (NYSE:MCK)

Aster Capital Management DIFC Ltd lifted its stake in McKesson Co. (NYSE:MCK) by 3,345.5% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 758 shares of the company’s stock after buying an additional 736 shares during the quarter. Aster Capital Management DIFC Ltd’s holdings in McKesson were worth $432,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other large investors have also recently made changes to their positions in the stock. Millstone Evans Group LLC purchased a new position in McKesson during the fourth quarter valued at approximately $28,000. Synergy Asset Management LLC bought a new stake in shares of McKesson during the 4th quarter valued at $32,000. Crews Bank & Trust bought a new stake in shares of McKesson during the 4th quarter valued at $33,000. Atala Financial Inc bought a new position in McKesson in the 4th quarter worth $34,000. Finally, Graney & King LLC purchased a new stake in McKesson in the 4th quarter worth $38,000. 85.07% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Several equities analysts have recently commented on MCK shares. Wells Fargo & Company boosted their price objective on McKesson from $641.00 to $691.00 and gave the company an “equal weight” rating in a research report on Friday, March 14th. StockNews.com cut McKesson from a “strong-buy” rating to a “buy” rating in a report on Friday, February 14th. Citigroup cut their price objective on shares of McKesson from $713.00 to $677.00 and set a “buy” rating for the company in a report on Friday, January 10th. Morgan Stanley boosted their target price on shares of McKesson from $642.00 to $745.00 and gave the stock an “overweight” rating in a report on Wednesday, April 2nd. Finally, Bank of America cut their target price on shares of McKesson from $680.00 to $650.00 and set a “buy” rating for the company in a research note on Monday, January 6th. Two equities research analysts have rated the stock with a hold rating, thirteen have issued a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $661.00.

McKesson Stock Performance

Shares of McKesson stock opened at $682.41 on Monday. The stock has a market cap of $85.52 billion, a price-to-earnings ratio of 31.25, a price-to-earnings-growth ratio of 1.29 and a beta of 0.49. The stock has a 50 day moving average price of $633.37 and a 200-day moving average price of $585.92. McKesson Co. has a one year low of $464.42 and a one year high of $728.32.

McKesson (NYSE:MCK) last posted its quarterly earnings data on Wednesday, February 5th. The company reported $8.03 earnings per share for the quarter, missing analysts’ consensus estimates of $8.60 by ($0.57). McKesson had a net margin of 0.82% and a negative return on equity of 181.26%. Sell-side analysts predict that McKesson Co. will post 32.77 earnings per share for the current fiscal year.

McKesson Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, April 1st. Shareholders of record on Monday, March 3rd were paid a $0.71 dividend. This represents a $2.84 annualized dividend and a yield of 0.42%. The ex-dividend date of this dividend was Monday, March 3rd. McKesson’s payout ratio is currently 13.00%.

Insider Buying and Selling at McKesson

In related news, CEO Brian S. Tyler sold 8,961 shares of the business’s stock in a transaction on Friday, February 21st. The stock was sold at an average price of $597.99, for a total transaction of $5,358,588.39. Following the completion of the transaction, the chief executive officer now owns 60,664 shares in the company, valued at $36,276,465.36. The trade was a 12.87 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, EVP Leann B. Smith sold 188 shares of the stock in a transaction on Wednesday, February 12th. The stock was sold at an average price of $609.59, for a total value of $114,602.92. Following the completion of the sale, the executive vice president now owns 1,051 shares in the company, valued at approximately $640,679.09. The trade was a 15.17 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 18,110 shares of company stock worth $10,855,706 over the last 90 days. Company insiders own 0.11% of the company’s stock.

McKesson Profile

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.